Literature DB >> 2835562

Cholinergic mediation in the ventral tegmental area of alpha-melanotropin induced excessive grooming: changes of the dopamine activity in the nucleus accumbens and caudate putamen.

E Torre1, M E Celis.   

Abstract

The effect of alpha-melanotropin (alpha-MSH) on the rat mesolimbic dopaminergic activity was estimated by measuring the changes in dihydroxyphenyl acetic acid (DOPAC) and dopamine (DA) endogenous levels in the nucleus accumbens (Ac) and caudate putamen (CP). A marked increase of DOPAC/DA ratios resulting from an increase in DOPAC and decrease in DA levels was found in the Ac 30 and 65 min after bilateral alpha-MSH-injections (1 microgram) into the ventral tegmental area (VTA). Similar changes were observed in the CP 65 min post-injections. These peptide-induced changes were completely inhibited by a previous VTA injection of atropine (1 microgram), at a dose that totally blocked the alpha-MSH-induced excessive grooming and motor activation. These results confirms that alpha-MSH affects a cholinergic afferent to the VTA which modifies the mesolimbic dopaminergic system involved in the alpha-MSH/ACTH-induced behaviors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835562     DOI: 10.1016/0024-3205(88)90444-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Effect of neuropeptide-EI on the binding of [3H]SCH 23390 to the dopamine D1 receptor in rat striatal membranes.

Authors:  M S Sanchez; N A Salvatierra; G Vettori; M E Celis
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

2.  Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats.

Authors:  Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2012-09-26       Impact factor: 4.530

3.  Decreased consumption of rewarding sucrose solutions after injection of melanocortins into the ventral tegmental area of rats.

Authors:  Haw-Han Yen; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

4.  Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.

Authors:  Rachel N Lippert; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2014-02-26       Impact factor: 4.736

5.  Altered sucrose self-administration following injection of melanocortin receptor agonists and antagonists into the ventral tegmental area.

Authors:  Laranci Shanmugarajah; Anna I Dunigan; Kyle J Frantz; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2017-02-27       Impact factor: 4.530

6.  Central melanocortins modulate mesocorticolimbic activity and food seeking behavior in the rat.

Authors:  Jon F Davis; Derrick L Choi; Jennifer D Shurdak; Eric G Krause; Maureen F Fitzgerald; Jack W Lipton; Randall R Sakai; Stephen C Benoit
Journal:  Physiol Behav       Date:  2010-12-21

7.  Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area.

Authors:  M S Sánchez; M Barontini; I Armando; M E Celis
Journal:  Cell Mol Neurobiol       Date:  2001-10       Impact factor: 5.046

8.  Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area.

Authors:  Katherine Stuhrman West; Chunxia Lu; David P Olson; Aaron G Roseberry
Journal:  J Physiol       Date:  2019-05-26       Impact factor: 5.182

9.  Participation of the cholinergic system in the excessive grooming behavior induced by neuropeptide (N) glutamic acid (E) isoleucine (I) amide (NEI).

Authors:  Victoria Berberian; Mónica Silvina Sanchez; María Ester Celis
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

10.  Alpha-melanocyte stimulating hormone and adrenocorticotropic hormone: an alternative approach when thinking about restless legs syndrome?

Authors:  Brian B Koo; Pingfu Feng; Jesse Dostal; Kingman P Strohl
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.